Circular RNAs in neuroblastoma: Pathogenesis, potential biomarker, and therapeutic target

Mohsen Karami Fath,Sasan Pourbagher Benam,Kiana Salmani,Sina Naderi,Zahra Fahham,Shamim Ghiabi,Seyed Armin Houshmand Kia,Malihe Naderi,Maryam Darvish,Ghasem Barati
DOI: https://doi.org/10.1016/j.prp.2022.154094
Abstract:Neuroblastoma (NB) is a common cancer in childhood responsible for 15 % of fatalities by pediatric cancers. Epigenetic factors play an important role in the pathogenesis of NB. Recently, it has been demonstrated that circular RNAs (circRNAs, ciRNAs), a newly identified class of non-coding RNAs, are also dysregulated in NB. CircRNAs mediate their functions by regulating gene expression mainly through microRNA (miRNA) sponging. The dysregulation (abnormal upregulation or downregulation) of circRNAs is involved in tumorigenesis of a variety of tumors including NB. It seems that the expression of some circRNAs is correlated with NB prognosis and clinical features. CircRNAs might be favorable as a diagnostic/prognostic biomarker and therapeutic target. However, due to the lack of studies, it is difficult to make a conclusion regarding the clinical benefits of circRNAs. In this review, we discussed the circRNAs that experimentally have been proved to be dysregulated in NB tissues and cancer cells.
What problem does this paper attempt to address?